secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xenetic Biosciences, Inc. (XBIO)
CIK:        0001534525
Form:       8-K
Filed at:   2025-10-14T23:59:59+00:00
Accession:  0001683168-25-007528
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Xenetic Biosciences prices $4.5M underwritten offering of 735,000 shares at $6.12/share
--------------------------------------------------------------------------------

- Offering of 735,000 common shares at $6.12 each for gross proceeds of ~$4.5M; net proceeds ~$3.9M after discounts and expenses.
- Expected to close on or about October 14, 2025, subject to customary closing conditions.
- Net proceeds to be used for working capital, general corporate purposes, and advancement of DNase technology.
- Canaccord Genuity is sole bookrunner; offering made under effective shelf registration statement (File No. 333-282756).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534525/000168316825007528/0001683168-25-007528-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534525/000168316825007528/xenetic_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-25-007528

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer